A Pilot Study to Evaluate the Feasibility, Safety and Engraftment of Zinc Finger Nuclease (ZFN) CCR5 Modified CD34+ Hematopoietic Stem/Progenitor Cells (SB-728mR-HSPC) in HIV-1 (R5) Infected Patients
Investigator(s):
Ronald Mitsuyasu, M.D.;
Organization:
UCLA
NCT Number:
Disease Name:
HIV
Disease Category:
Trial Phases:
Phase 1
Trial Status:
Recruiting
Trial Contact:
Maricela Gonzalez
(310) 557-3729
mmgonzalez@mednet.ucla.edu